Front Matter

(nextflipdebug5) #1

500 Canine Sports Medicine and Rehabilitation


Martenson, M. E., Cetas, J. S. & Heinricher, M. M.



  1. A possible neural basis for stress‐induced
    hyperalgesia. Pain, 142, 236–244.
    Martins, T. L., Kahvegian, M. A., Noel‐Morgan, J.,
    Leon‐Roman, M. A., Otsuki, D. A. & Fantoni, D. T.

  2. Comparison of the effects of tramadol,
    codeine, and ketoprofen alone or in combination
    on postoperative pain and on concentrations of
    blood glucose, serum cortisol, and serum interleu-
    kin‐6 in dogs undergoing maxillectomy or man-
    dibulectomy. Am J Vet Res, 71, 1019–1026.
    Mathews, K. A. 2008. Neuropathic pain in dogs and
    cats: if only they could tell us if they hurt. Vet Clin
    North Am Small Anim Pract, 38, 1365–1414.
    Mathews, K., Kronen, P. W., Lascelles, D., Nolan, A.,
    Robertson, S., Steagall, P. V., et al. 2014. Guidelines
    for recognition, assessment and treatment of pain.
    J Small Anim Pract, 55(6), E10–68.
    Mburu, D. N., Mbugua, S. W., Skoglund, L. A. &
    Lokken, P. 1988. Effects of paracetamol and acetyl-
    salicylic acid on the post‐operative course after
    experimental orthopaedic surgery in dogs. J Vet
    Pharmacol Ther, 11, 163–170.
    McConkey, S. E., Grant, D. M. & Cribb, A. E. 2009.
    The role of para‐aminophenol in acetaminophen‐
    induced methemoglobinemia in dogs and cats.
    J Vet Pharmacol Ther, (6), 585–595.
    McNicol, E. & Carr, D. B. 2007. Opioid side effects.
    IASP Pain Clin Updates,15(2), 1–6.
    Mehler, S. J., May, L. R., King, C., Harris, W. S. &
    Shah, Z. 2016. A prospective, randomized, double
    blind, placebo‐controlled evaluation of the effects
    of eicosapentaenoic acid and docosahexaenoic
    acid on the clinical signs and erythrocyte mem-
    brane polyunsaturated fatty acid concentrations in
    dogs with osteoarthritis. Prostaglandins Leukot
    Essent Fatty Acids, 109, 1–7.
    Mohammed, S. I., Khan, K. N., Sellers, R. S., Hayek,
    M. G., Denicola, D. B., Wu, L., et al. 2004. Expression
    of cyclooxygenase‐1 and 2 in naturally‐occurring
    canine cancer. Prostaglandins Leukot Essent Fatty
    Acids, 70, 479–483.
    Moore, S. A. 2016. Managing neuropathic pain in
    dogs. Front Vet Sci, 3, 12.
    Moll, X., Fresno, L., Garcia, F., Prandi, D. & Andaluz,
    A. 2011. Comparison of subcutaneous and trans-
    dermal administration of buprenorphine for
    pre‐emptive analgesia in dogs undergoing elec-
    tive ovariohysterectomy. Vet J, 187, 124–128.
    Muehlbacher, M., Nickel, M. K., Kettler, C., Tritt, K.,
    Lahmann, C., Leiberich, P. K., et  al. 2006.
    Topiramate in treatment of patients with chronic
    low back pain: a randomized, double‐blind, pla-
    cebo‐controlled study. Clin J Pain, 22, 526–531.
    Muir, W. W., 3rd, Wiese, A. J. & March, P. A. 2003.
    Effects of morphine, lidocaine, ketamine, and mor-


phine‐lidocaine‐ketamine drug combination on
minimum alveolar concentration in dogs anesthe-
tized with isoflurane. Am J Vet Res, 64, 1155–1160.
Neil, M. J. 2011. Clonidine: clinical pharmacology
and therapeutic use in pain management. Curr
Clin Pharmacol, 6, 280–287.
Neirinckx, E., Vervaet, C., DE Boever, S., Remon, J. P.,
Gommeren, K., Daminet, S., et  al. 2010. Species
comparison of oral bioavailability, first‐pass
metabolism and pharmacokinetics of acetami-
nophen. Res Vet Sci, 89(1), 113–119.
Norkus, C., Rankin, D. & Kukanich, B. 2015.
Evaluation of the pharmacokinetics of oral ami-
triptyline and its active metabolite nortriptyline in
fed and fasted Greyhound dogs. J Vet Pharmacol
Ther, 38(6), 619–622.
Patel, D. S, Deshpande, S. S, Patel, C. G. & Singh, S.


  1. Duloxetine: a dual action antidepressant.
    Indo‐Glob J Pharml Sci, 1(1), 63–76.
    Payne‐Johnson, M., Becskei, C., Chaudhry, Y. &
    Stegemann, M. R. 2015. Comparative efficacy and
    safety of mavacoxib and carprofen in the treat-
    ment of canine osteoarthritis. Vet Rec, 176(11), 284.
    Pieper, K., Schuster, T., Levionnois, O., Matis, U. &
    Bergadano, A. 2011. Antinociceptive efficacy and
    plasma concentrations of transdermal buprenor-
    phine in dogs. Vet J, 187, 335–341.
    Plessas, I. N., Volk, H. A., Rusbridge, C.,
    Vanhaesebrouck, A. E. & Jeffery, N. D. 2015.
    Comparison of gabapentin versus topiramate on
    clinically affected dogs with Chiari‐like malforma-
    tion and syringomyelia. Vet Rec, 177(11), 288.
    Plumb, D. C. 2011. Plumb’s Veterinary Drug Handbook,
    7th edn. Stockholm, WI: PharmaVet.
    Rausch‐Derra, L. C., Huebner, M. & Rhodes, L. 2015.
    Evaluation of the safety of long‐term, daily oral
    administration of grapiprant, a novel drug for
    treatment of osteoarthritic pain and inflammation,
    in healthy dogs. Am J Vet Res, 76(10), 853–859.
    Rausch‐Derra, L., Huebner, M., Wofford, J. & Rhodes,
    L. 2016. A prospective, randomized, masked, pla-
    cebo‐controlled multisite clinical study of grap-
    iprant, an EP4 prostaglandin receptor antagonist
    (PRA), in dogs with osteoarthritis. J Vet Intern Med,
    30(3), 756–763.
    Ray, L., Lipton, R. B., Zimmerman, M. E., Katz, M. J.
    & Derby, C. A. 2011. Mechanisms of association
    between obesity and chronic pain in the elderly.
    Pain, 152, 53–59.
    Sackett, D. L., Rosenberg, W. M., Gray, J. A., Haynes,
    R. B. & Richardson, W. S. 1996. Evidence based
    medicine: what it is and what it isn’t. BMJ,
    312, 71–72.
    Salazar, V., Dewey, C. W., Schwark, W., Badgley, B. L.,
    Gleed, R. D., Horne, W. & Ludders, J. W. 2009.
    Pharmacokinetics of single‐dose oral pregabalin

Free download pdf